You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美股異動 | Castle Biosciences(CSTL.US)跌12.46% 公司宣佈收購AltheaDx 加通貝祥下調目標價
格隆匯 04-06 00:18
格隆匯4月6日丨Castle Biosciences(CSTL.US)跌12.46%,報40.26美元。公司昨日表示,已簽署收購AltheaDx Inc.的最終協議,該收購旨在給公司增加精神健康測試解決方案。Castle Biosciences初步將支付6500萬美元,現金和普通股各佔一半。如果業績達到協議中的里程碑,並擴大IDgene tix的醫療保險覆蓋範圍,Castle Biosciences將額外支付高達7500萬美元的現金和普通股。加通貝祥今日將Castle Biosciences目標價從94美元下調至80美元,維持買入評級。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account